SCHEMBL5814835

SCHEMBL5814835

Cc1cccc(-c2nc(N3CCCCC3)sc2-c2ccnc(NC3CC3)n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.48
BRAF P15056 1/20 0.45
KCNH2 Q12809 1/20 0.44
CDK4 P11802 6/20 0.43
CCND1 P24385 3/20 0.43
CCND3 P30281 1/20 0.43
CDK6 Q00534 1/20 0.43
GSK3B P49841 2/20 0.42
RIPK2 O43353 1/20 0.42
MAPK10 P53779 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
CDK2 P24941 4/20 0.40
CCNA2 P20248 3/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNA1 P78396 2/20 0.40
PDE10A Q9Y233 1/20 0.40
IKBKB O14920 1/20 0.39
MAPK3 P27361 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819465 0.97 MAPK14 (0.51) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5815238 0.92 MAPK14 (0.45) MAPK14BRAFKCNH2CDK4GSK3B
SCHEMBL5813776 0.92 MAPK14 (0.45) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5815400 0.91 MAPK14 (0.49) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5814087 0.91 KCNH2 (0.49) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5814546 0.90 KCNH2 (0.49) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5817861 0.90 MAPK14 (0.50) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5817136 0.89 KCNH2 (0.49) MAPK14BRAFKCNH2CDK4CCND1
SCHEMBL5823204 0.89 CAMK2D (0.47) BRAFKCNH2CDK4GSK3BRIPK2
SCHEMBL5816373 0.89 BRAF (0.53) MAPK14BRAFKCNH2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed